CRISPR Therapeutics AG
NASDAQ:CRSP
CRISPR Therapeutics AG
NASDAQ:CRSP
Price:
48.75
USD
-0.25%
Market Closed
Market Cap:
$4.6B
Wall Street
Price Targets
CRSP Price Targets Summary
CRISPR Therapeutics AG
CRISPR Therapeutics AG
Wall Street analysts forecast CRSP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
CRSP
is 84.28 USD
with a low forecast of 33.33 USD and a high forecast of 330.75 USD.
Lowest
Price Target
33.33
USD
32% Downside
Average
Price Target
84.28
USD
73% Upside
Highest
Price Target
330.75
USD
578% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CRSP's stock price target?
Price Target
84.28
USD
84.28
USD
According to Wall Street analysts, the average 1-year price target for
CRSP
is 84.28 USD
with a low forecast of 33.33 USD and a high forecast of 330.75 USD.
What is CRISPR Therapeutics AG's Revenue forecast?
Projected CAGR
463%
463%
For the last 10 years the
compound annual growth rate for
CRISPR Therapeutics AG's revenue is
33%.
The projected
CAGR
for the next 3 years is
463%.
